BRLLD Financials

BRLLD

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE September

This page shows BRLLD (BRLLD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 15/100

Based on FY2020 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of BRLLD's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

BRLLD carries a low D/E ratio of -3.21, meaning only $-3.21 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 87/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

BRLLD's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Earnings Quality Low Quality

0.05x

For every $1 of reported earnings, BRLLD generates $0.05 in operating cash flow (-$141K OCF vs -$2.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$2.7M

YoY-59.9%

BRLLD reported -$2.7M in net income in fiscal year 2020. This represents a decrease of 59.9% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

BRLLD held $0 in cash against $0 in long-term debt as of fiscal year 2020.

Dividends Per Share

N/A

Shares Outstanding

292M

BRLLD had 292M shares outstanding in fiscal year 2020. This represents an increase of 609.7% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

BRLLD Income Statement

Metric	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$11K-70.4%	$38K-7.5%	$41K-4.9%	$43K+29.8%	$33K-10.6%	$37K
Operating Income	N/A	N/A	-$171K-93.5%	-$88K-164.9%	-$33K+10.6%	-$37K
Interest Expense	$31K-83.6%	$186K+3710.1%	-$5K-169.6%	$7K+3.4%	$7K-4.7%	$8K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$2.7M-59.9%	-$1.7M-875.6%	-$176K-147.6%	-$71K-78.3%	-$40K+12.1%	-$45K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q2'25	Q4'20	Q2'20	Q1'20	Q4'19	Q3'19
Revenue	$42K	N/A	$45K	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$23K	N/A	$15K	N/A	N/A	N/A	N/A	N/A
Gross Profit	$20K	N/A	$30K	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$10K	N/A	$7K	N/A	$32K+100.5%	$16K	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	-$7K	N/A	N/A
Income Tax	$0	N/A	$0	N/A	N/A	N/A	N/A	N/A
Net Income	-$6K	N/A	$17K	N/A	-$975K-592.5%	-$141K	N/A	N/A
EPS (Diluted)	$-0.01	N/A	$0.02	N/A	N/A	N/A	N/A	N/A

BRLLD Balance Sheet

Metric	FY20	FY19	FY18	FY17	FY16	FY15
Total Assets	$3.8M	$0-100.0%	$37K-85.3%	$250K+444.9%	$46K+1.6%	$45K
Current Assets	$0	$0-100.0%	$37K-85.3%	$250K+75706.1%	$330-27.5%	$455
Cash & Equivalents	$0	$0-100.0%	$3K-98.6%	$250K+75706.1%	$330-27.5%	$455
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.5M+361.0%	$1.2M+956.9%	$113K-23.5%	$148K+23.5%	$120K+22.0%	$98K
Current Liabilities	$1.8M+47.3%	$1.2M+956.9%	$113K-23.5%	$148K+23.5%	$120K+47.1%	$81K
Long-Term Debt	N/A	N/A	$75K+3.2%	$73K-19.9%	$91K+10.5%	$83K
Total Equity	-$1.7M-43.7%	-$1.2M-1465.6%	-$76K-174.8%	$102K+238.2%	-$74K-39.5%	-$53K
Retained Earnings	-$21.2M-908.5%	-$2.1M-493.2%	-$355K-98.6%	-$178K-66.2%	-$107K-59.1%	-$67K

Metric	Q2'26	Q1'26	Q2'25	Q4'20	Q2'20	Q1'20	Q4'19	Q3'19
Total Assets	$104K-11.5%	$117K	N/A	$3.8M-2.4%	$3.9M-2.0%	$4.0M	$0-100.0%	$13K
Current Assets	$79K-32.8%	$117K	N/A	$0-100.0%	$313+3377.8%	$9	$0-100.0%	$13K
Cash & Equivalents	$4K-91.8%	$52K+61.8%	$32K	$0-100.0%	$313+3377.8%	$9	$0-100.0%	$13K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$52K+21.4%	$43K	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$59K-11.0%	$67K	N/A	$5.5M-5.6%	$5.8M+14.2%	$5.1M+327.7%	$1.2M+81.4%	$659K
Current Liabilities	$59K-11.0%	$67K	N/A	$1.8M-20.8%	$2.2M+31.5%	$1.7M+41.4%	$1.2M+81.4%	$659K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$45K-12.2%	$51K+312.6%	$12K+100.7%	-$1.7M+12.0%	-$2.0M-70.2%	-$1.1M+4.0%	-$1.2M-85.0%	-$647K
Retained Earnings	-$317K-202.0%	$311K	N/A	-$21.2M-8.3%	-$19.6M-5.2%	-$18.6M-784.9%	-$2.1M-35.4%	-$1.6M

BRLLD Cash Flow Statement

Metric	FY20	FY19	FY18	FY17	FY16	FY15
Operating Cash Flow	-$141K+79.4%	-$684K	N/A	$9K+139.5%	-$22K+41.6%	-$38K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	N/A	N/A	N/A	N/A
Financing Cash Flow	$127K-81.1%	$669K+2160.4%	-$32K-113.0%	$250K+1021.6%	$22K-35.4%	$35K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q2'25	Q4'20	Q2'20	Q1'20	Q4'19	Q3'19
Operating Cash Flow	-$23K	N/A	-$79K	N/A	-$51K-396.8%	-$10K+66.3%	-$30K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$25K	N/A	-$40K	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$25K	N/A	$0	N/A	$28K+22.8%	$22K+4608.8%	-$499	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BRLLD Financial Ratios

Metric	FY20	FY19	FY18	FY17	FY16	FY15
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	-69.6%	N/A	N/A
Return on Assets	-72.3%	N/A	-478.5%-450.0pp	-28.4%+58.4pp	-86.9%+13.5pp	-100.4%
Current Ratio	0.000.0	0.00-0.3	0.33-1.4	1.69+1.7	0.000.0	0.01
Debt-to-Equity	-3.21-2.2	-1.00-0.0	-0.99-1.7	0.71+1.9	-1.23+0.3	-1.56
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q2'25	Q4'20	Q2'20	Q1'20	Q4'19	Q3'19
Gross Margin	46.2%	N/A	66.4%	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-14.6%	N/A	37.3%	N/A	N/A	N/A	N/A	N/A
Return on Equity	-13.9%	N/A	136.9%	N/A	N/A	N/A	N/A	N/A
Return on Assets	-5.9%	N/A	N/A	N/A	-25.1%-21.5pp	-3.5%	N/A	N/A
Current Ratio	1.33-0.4	1.76	N/A	0.000.0	0.000.0	0.000.0	0.00-0.0	0.02
Debt-to-Equity	1.33+0.0	1.31	N/A	-3.21-0.2	-2.99+1.5	-4.46-3.5	-1.00+0.0	-1.02
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is BRLLD profitable?

No, BRLLD (BRLLD) reported a net income of -$2.7M in fiscal year 2020.

What is BRLLD's operating cash flow?

BRLLD (BRLLD) generated -$141K in operating cash flow during fiscal year 2020, representing cash generated from core business activities.

What are BRLLD's total assets?

BRLLD (BRLLD) had $3.8M in total assets as of fiscal year 2020, including both current and long-term assets.

How many shares does BRLLD have outstanding?

BRLLD (BRLLD) had 292M shares outstanding as of fiscal year 2020.

What is BRLLD's current ratio?

BRLLD (BRLLD) had a current ratio of 0.00 as of fiscal year 2020, which is below 1.0, which may suggest potential liquidity concerns.

What is BRLLD's debt-to-equity ratio?

BRLLD (BRLLD) had a debt-to-equity ratio of -3.21 as of fiscal year 2020, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is BRLLD's return on assets (ROA)?

BRLLD (BRLLD) had a return on assets of -72.3% for fiscal year 2020, measuring how efficiently the company uses its assets to generate profit.

What is BRLLD's cash runway?

Based on fiscal year 2020 data, BRLLD (BRLLD) had $0 in cash against an annual operating cash burn of $141K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is BRLLD's debt-to-equity ratio negative or unusual?

BRLLD (BRLLD) has negative shareholder equity of -$1.7M as of fiscal year 2020, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Are BRLLD's earnings high quality?

BRLLD (BRLLD) has an earnings quality ratio of 0.05x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is BRLLD?

BRLLD (BRLLD) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.